The US Food and Drug Administration’s fiscal year 2024 budget would grow around $17m under a House appropriations bill which, along with other spending proposals, is on hold as negotiations over the country’s debt limit continue between the White House and GOP leaders.
The Appropriations Committee’s Agriculture, Rural Development, FDA and Related Agencies Subcommittee on 18 May marked up its bill for...





